Contract Description
Contract Awarded For Medicinal Products For The Treatment Of Cystic Fibrosis
the Subject Of The Public Contract Is The Ongoing Supply Of Medicinal Products Containing Ivacaftor, Tezacaftor, And Elexacaftor Until April 11, 2027, And Medicinal Products Cont